ClinicalTrialsFinder
RecruitingPhase 1NCT07711561

Simple Non-cultured Endothelial Cell Therapy for Corneal Endothelial Dysfunction

Safety and Efficacy of Simple Non-cultured Endothelial Cell Injection(SNEC-I) Therapy for Corneal Endothelial Dysfunction

Sponsor

Singapore Eye Research Institute

Enrollment

20 participants

Start Date

Jun 22, 2026

Study Type

INTERVENTIONAL

Conditions

Bullous KeratopathyCorneal Endothelial Dystrophy

Summary

Assessment of safety and efficacy of cell injection therapy generated using non-cultured human corneal endothelial cells in treating corneal endothelial dysfunction

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a biological treatment called Cell injection for people with bullous keratopathy and corneal endothelial dystrophy. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BIOLOGICALCell injection

Direct endothelial cell injection of non-cultured corneal endothelial cells

Locations(1)

L V Prasad Eye Institute

Hyderabad, Telangana, India

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07711561

Related Trials

The Belgian Endothelial Surgical Transplant of the Cornea

NCT0543666511 locations

Study to Assess Safety and Tolerability of Multiple Doses of EO2002

NCT056365791 location

Safety and Efficacy of Tissue Engineered Endothelial Keratoplasty

NCT043198481 location